Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027
E Tuaillon
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
K Bolloré
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
A Pisoni
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
S Debiesse
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
C Renault
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France.
S Marie
3Montpellier University Hospital, Montpellier, France.
C Soraya
3Montpellier University Hospital, Montpellier, France.
C Niels
3Montpellier University Hospital, Montpellier, France.
N Pansu
3Montpellier University Hospital, Montpellier, France.
D Morquin
3Montpellier University Hospital, Montpellier, France.
V Foulongne
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
A Bourdin
3Montpellier University Hospital, Montpellier, France.
V Le Moing
3Montpellier University Hospital, Montpellier, France.
P Van de Perre
1Pathogenesis, and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France.
Data Availability
Not available
Posted May 08, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, C Soraya, C Niels, N Pansu, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12506)
- Forensic Medicine (10)
- Gastroenterology (797)
- Genetic and Genomic Medicine (4372)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2821)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (889)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4140)
- Nursing (219)
- Nutrition (614)
- Oncology (2178)
- Ophthalmology (618)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (261)
- Palliative Medicine (81)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6725)
- Radiology and Imaging (1477)
- Respiratory Medicine (893)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)